Incorporated in 2010, EVOQ Remedies Limited specializes in offering quality Pharmaceuticals Raw Material products, Excipients, and Bulk Drugs at an affordable prices. The company procures all the products from WHO-GMP certified & reliable Manufacturers & Importers, who follow procedures as per the stringent national and international quality and safety standards.
- Experienced Management Team.
- Continue to develop client relationships and Trust.
- Supplying the best quality products at the most reasonable prices.
Mr. Bhumishth Narendrabhai Patel and Mrs. Payal Bhumishth Patel are the company promoters.
|Particulars||For the year/period ended (Rs in Lakh)|
|Profit After Tax||93.67||71.38||0.03||1.11|
Objects of the Issue:
The Issue Proceeds from the Fresh Issue will be utilized towards the following objects:
- To Meet Incremental Working Capital Requirements.
- General Corporate Purpose.
- To meet Public Issue Expenses.
Evoq Remedies IPO Details
|IPO Opening Date||Mar 17, 2022|
|IPO Closing Date||Mar 22, 2022|
|Issue Type||Fixed Price Issue IPO|
|Face Value||₹10 per equity share|
|IPO Price||₹27 per equity share|
|Market Lot||4000 Shares|
|Min Order Quantity||4000 Shares|
|Listing At||BSE SME|
|Issue Size||3,600,000 Eq Shares of ₹10|
(aggregating up to ₹9.72 Cr)
|Fresh Issue||3,600,000 Eq Shares of ₹10|
(aggregating up to ₹9.72 Cr)
|Retail Shares Offered||50%|
|NII (HNI) Shares Offered||50%|
Evoq Remedies IPO Tentative Timetable
The Evoq Remedies IPO open date is Mar 17, 2022, and the close date is Mar 22, 2022. The issue may list on Mar 30, 2022.
|IPO Open Date||Mar 17, 2022|
|IPO Close Date||Mar 22, 2022|
|Basis of Allotment Date||Mar 25, 2022|
|Initiation of Refunds||Mar 28, 2022|
|Credit of Shares to Demat Account||Mar 29, 2022|
|IPO Listing Date||Mar 30, 2022|
Evoq Remedies IPO Lot Size
The Evoq Remedies IPO market lot size is 4000 shares. A retail-individual investor can apply for up to 1 lots (4000 shares or ₹108,000).
Evoq Remedies IPO Promoter Holding
|Pre Issue Share Holding||99.99%|
|Post Issue Share Holding||73.53%|
3rd Party IPO Application
SBI Bank, Axis Bank, Bank of Baroda (BoB), RBL Bank and IndusInd Bank.
Evoq Remedies IPO Review
The company has posted a lacklustre performance so far. The sudden boost in bottom lines since FY21 onwards appears window dressing to pave the way for fancy pricing of this IPO. The sustainability of such performance going forward is a major concern. Based on its financial parameters, the issue is aggressively priced. It is operating on third party deals only and has no assets. Considering all these, there is no harm in ignoring this highly-priced IPO.
Company Contact Information
Evoq Remedies Limited
A-1106, Empire Business Hub
Near AUDA Water Tank,
Science City Road, Sola, Ahmedabad-380060
Evoq Remedies IPO Registrar
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200